Physician profile
Rylee Lynn Storms
NPI 1356152334
$253.77
in general payments reported to CMS, 2019-2025
11 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $53.61 | 2025 | |
| Ucb, INC. | $30.66 | 2025 | Briviact |
| Eisai INC. | $28.88 | 2025 | |
| Aucta Pharmaceuticals, INC. | $23.90 | 2025 | Motpoly Xr |
| Lundbeck LLC | $21.06 | 2025 | Rexulti |
| Stryker Corporation | $19.84 | 2025 | Spinejack |
| Alexion Pharmaceuticals, INC. | $18.07 | 2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $15.61 | 2025 | Austedo Xr |
| Abbvie INC. | $14.40 | 2025 | |
| Acadia Pharmaceuticals INC | $14.26 | 2025 | Daybue |
| Lilly USA, LLC | $13.48 | 2025 | Kisunla, Amyvid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rylee Storms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.